共 50 条
- [41] Transient asymptomatic pulmonary opacities and interstitial lung disease in EGFR-mutated non-small cell lung cancer treated with osimertinibTUMORI JOURNAL, 2022, 108 (06): : 592 - 599Taronna, GianlucaLeonetti, AlessandroDall'Olio, Filippo GustavoRizzo, AlessandroParisi, ClaudiaButi, SebastianoBordi, PaolaBrocchi, StefanoGolfieri, RitaArdizzoni, AndreaSverzellati, NicolaTiseo, Marcello
- [42] Critical points in the management of EGFR-mutated non-small cell lung cancerJOURNAL OF THORACIC DISEASE, 2022, 14 (06) : 1748 - 1752Casaluce, FrancescaGridelli, Cesare
- [43] Optimizing adjuvant therapy in EGFR-mutated non-small cell lung cancerANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (23)Shepherd, Annemarie F.Preeshagul, Isabel R.Shaverdian, NarekWu, Abraham J.Gelblum, Daphna Y.Gomez, Daniel R.Rimner, AndreasSimone, Charles B., II
- [44] NEUROLOGICAL EVOLUTION OF A PATIENT WITH EGFR-MUTATED NON-SMALL CELL LUNG CANCERCHEST, 2022, 161 (06) : 333A - 333AIanza, A.Dicorato, A.Guglielmi, A.Orlando, V.Furlanis, G.Curro, F.
- [45] Depression and Inflammation in Patients with EGFR-Mutated Non-Small Cell Lung CancerJOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S871 - S871Cardona, A.Arrieta, O.Rojas, L.Zatarain-Barron, Z.Ricaurte, L.Ruiz-Patino, A.Martin, C.Carranza, H.Vargas, C.Otero, J.Corrales, L.
- [46] Adjuvant Osimertinib in Resected EGFR-Mutated Stage IBeIIIA Non-Small Cell Lung Cancer: Updated ADAURA ResultsJOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : E4 - E4Herbst, R. S.Wu, Y. -L.Grohe, C.John, T.Majem, M.Wang, J.Kato, T.Goldman, J. W.Kim, S. -W.Yu, C. -J.Vu, H. V.Mukhametshina, G.Akewanlop, C.de Marinis, F.Shepherd, F. A.Urban, D.Stachowiak, M.Bolanos, A.Huang, X.Tsuboi, M.
- [47] Effectiveness of osimertinib plus chemotherapy and avastin for EGFR-mutated advanced non-small cell lung cancer with brain metastasesANNALS OF ONCOLOGY, 2021, 32 : S967 - S967Qin, H.Wang, S.Gao, F.Zeng, Z.Liu, X.
- [48] Cost-effectiveness of osimertinib versus placebo in resected EGFR-mutated non-small cell lung cancer in ChinaCANCER MEDICINE, 2022, 11 (23): : 4449 - 4456Zhou, XiwenDu, JiantingXu, GuobingChen, ChunZheng, BinChen, Jiahe
- [49] Osimertinib as Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: A Case SeriesFRONTIERS IN PHARMACOLOGY, 2022, 13Hu, YanRen, SiyingYang, LuluTong, ZhongyiWang, RuoyaoHan, WeiZeng, ChaoLi, JinaXiao, PengWang, LiYu, FengleiLiu, Wenliang
- [50] MERTK drives residual tumor growth in EGFR-mutated non-small cell lung cancer cells treated with osimertinibCANCER RESEARCH, 2020, 80 (16)Yan, DanHuelse, JustusParker, RebeccaTan, ZikangWang, XiaodongFrye, Stephen, VEarp, H. SheltonDeRyckere, DeborahGraham, Douglas K.